annual D&A:
$189.00M-$432.00M(-69.57%)Summary
- As of today (May 20, 2025), MRNA annual depreciation & amortization is $189.00 million, with the most recent change of -$432.00 million (-69.57%) on December 31, 2024.
- During the last 3 years, MRNA annual D&A has fallen by -$43.00 million (-18.53%).
- MRNA annual D&A is now -69.57% below its all-time high of $621.00 million, reached on December 31, 2023.
Performance
MRNA Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$39.00M-$21.00M(-35.00%)Summary
- As of today (May 20, 2025), MRNA quarterly depreciation & amortization is $39.00 million, with the most recent change of -$21.00 million (-35.00%) on March 31, 2025.
- Over the past year, MRNA quarterly D&A has increased by +$3.00 million (+8.33%).
- MRNA quarterly D&A is now -84.34% below its all-time high of $249.00 million, reached on September 30, 2023.
Performance
MRNA quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$192.00M+$3.00M(+1.59%)Summary
- As of today (May 20, 2025), MRNA TTM depreciation & amortization is $192.00 million, with the most recent change of +$3.00 million (+1.59%) on March 31, 2025.
- Over the past year, MRNA TTM D&A has dropped by -$387.00 million (-66.84%).
- MRNA TTM D&A is now -69.08% below its all-time high of $621.00 million, reached on December 31, 2023.
Performance
MRNA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
MRNA Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.6% | +8.3% | -66.8% |
| 3 y3 years | -18.5% | -50.6% | -35.1% |
| 5 y5 years | +509.7% | +457.1% | +525.7% |
MRNA Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -69.6% | at low | -84.3% | +8.3% | -69.1% | +1.6% |
| 5 y | 5-year | -69.6% | +509.7% | -84.3% | +457.1% | -69.1% | +525.7% |
| alltime | all time | -69.6% | >+9999.0% | -84.3% | >+9999.0% | -69.1% | >+9999.0% |
MRNA Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $39.00M(-35.0%) | $192.00M(+1.6%) |
| Dec 2024 | $189.00M(-69.6%) | $60.00M(+15.4%) | $189.00M(-42.9%) |
| Sep 2024 | - | $52.00M(+26.8%) | $331.00M(-37.3%) |
| Jun 2024 | - | $41.00M(+13.9%) | $528.00M(-8.8%) |
| Mar 2024 | - | $36.00M(-82.2%) | $579.00M(-6.8%) |
| Dec 2023 | $621.00M(+78.4%) | $202.00M(-18.9%) | $621.00M(+24.4%) |
| Sep 2023 | - | $249.00M(+170.7%) | $499.00M(+37.5%) |
| Jun 2023 | - | $92.00M(+17.9%) | $363.00M(+4.6%) |
| Mar 2023 | - | $78.00M(-2.5%) | $347.00M(-0.3%) |
| Dec 2022 | $348.00M(+50.0%) | $80.00M(-29.2%) | $348.00M(+0.6%) |
| Sep 2022 | - | $113.00M(+48.7%) | $346.00M(+14.2%) |
| Jun 2022 | - | $76.00M(-3.8%) | $303.00M(+2.4%) |
| Mar 2022 | - | $79.00M(+1.3%) | $296.00M(+27.6%) |
| Dec 2021 | $232.00M(+648.4%) | $78.00M(+11.4%) | $232.00M(+44.1%) |
| Sep 2021 | - | $70.00M(+1.4%) | $161.00M(+61.0%) |
| Jun 2021 | - | $69.00M(+360.0%) | $100.00M(+156.4%) |
| Mar 2021 | - | $15.00M(+114.3%) | $39.00M(+25.8%) |
| Dec 2020 | $31.00M(0.0%) | $7.00M(-22.2%) | $31.00M(-5.9%) |
| Sep 2020 | - | $9.00M(+12.5%) | $32.95M(+5.6%) |
| Jun 2020 | - | $8.00M(+14.3%) | $31.21M(+1.7%) |
| Mar 2020 | - | $7.00M(-21.8%) | $30.68M(-1.0%) |
| Dec 2019 | $31.00M(+24.7%) | $8.95M(+23.5%) | $31.00M(+5.5%) |
| Sep 2019 | - | $7.25M(-3.0%) | $29.40M(+2.7%) |
| Jun 2019 | - | $7.48M(+2.2%) | $28.62M(+5.9%) |
| Mar 2019 | - | $7.32M(-0.5%) | $27.02M(+8.7%) |
| Dec 2018 | $24.86M(+21.1%) | $7.35M(+13.4%) | $24.86M(+41.0%) |
| Sep 2018 | - | $6.48M(+10.3%) | $17.64M(+56.4%) |
| Jun 2018 | - | $5.88M(+14.1%) | $11.28M(+104.8%) |
| Mar 2018 | - | $5.15M(+4079.2%) | $5.51M(+1121.0%) |
| Dec 2017 | $20.54M(+35.9%) | $123.30K(+0.2%) | $450.90K(+19.7%) |
| Sep 2017 | - | $123.00K(+15.8%) | $376.80K(+48.5%) |
| Jun 2017 | - | $106.20K(+7.9%) | $253.80K(+72.0%) |
| Mar 2017 | - | $98.40K(+100.0%) | $147.60K(+200.0%) |
| Dec 2016 | $15.11M(+2623.2%) | - | - |
| Dec 2016 | - | $49.20K(>+9900.0%) | $49.20K(>+9900.0%) |
| Sep 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2012 | $555.00K(-55.6%) | $0.00(-100.0%) | $555.00K(-30.7%) |
| Sep 2012 | - | $160.00K(-4.2%) | $801.00K(-15.0%) |
| Jun 2012 | - | $167.00K(-26.8%) | $942.00K(-15.7%) |
| Mar 2012 | - | $228.00K(-7.3%) | $1.12M(-10.6%) |
| Dec 2011 | $1.25M(-20.8%) | $246.00K(-18.3%) | $1.25M(-9.5%) |
| Sep 2011 | - | $301.00K(-12.2%) | $1.38M(-5.1%) |
| Jun 2011 | - | $343.00K(-5.0%) | $1.46M(-3.2%) |
| Mar 2011 | - | $361.00K(-4.2%) | $1.50M(-4.8%) |
| Dec 2010 | $1.58M(-33.3%) | $377.00K(+0.5%) | $1.58M(-6.1%) |
| Sep 2010 | - | $375.00K(-4.1%) | $1.68M(-9.7%) |
| Jun 2010 | - | $391.00K(-10.5%) | $1.86M(-10.5%) |
| Mar 2010 | - | $437.00K(-9.0%) | $2.08M(-12.1%) |
| Dec 2009 | $2.37M | $480.00K(-13.7%) | $2.37M(-9.9%) |
| Sep 2009 | - | $556.00K(-8.9%) | $2.63M(-14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $610.00K(-15.6%) | $3.08M(-16.4%) |
| Mar 2009 | - | $723.00K(-2.4%) | $3.69M(-10.4%) |
| Dec 2008 | $4.11M(-6.3%) | $741.00K(-26.5%) | $4.11M(-9.0%) |
| Sep 2008 | - | $1.01M(-17.1%) | $4.52M(-3.0%) |
| Jun 2008 | - | $1.22M(+5.8%) | $4.66M(+2.8%) |
| Mar 2008 | - | $1.15M(+0.1%) | $4.53M(+3.2%) |
| Dec 2007 | $4.39M(+51.3%) | $1.15M(+0.1%) | $4.39M(+4.8%) |
| Sep 2007 | - | $1.15M(+5.2%) | $4.19M(+10.6%) |
| Jun 2007 | - | $1.09M(+8.2%) | $3.79M(+13.9%) |
| Mar 2007 | - | $1.01M(+6.4%) | $3.33M(+14.6%) |
| Dec 2006 | $2.90M(+58.5%) | $946.00K(+26.6%) | $2.90M(+16.1%) |
| Sep 2006 | - | $747.00K(+19.1%) | $2.50M(+13.0%) |
| Jun 2006 | - | $627.00K(+7.5%) | $2.21M(+9.6%) |
| Mar 2006 | - | $583.00K(+7.4%) | $2.02M(+10.2%) |
| Dec 2005 | $1.83M(+27.0%) | $543.00K(+18.0%) | $1.83M(+11.1%) |
| Sep 2005 | - | $460.00K(+6.2%) | $1.65M(+6.7%) |
| Jun 2005 | - | $433.00K(+9.3%) | $1.55M(-0.8%) |
| Mar 2005 | - | $396.00K(+10.0%) | $1.56M(+8.0%) |
| Dec 2004 | $1.44M(+2.1%) | $360.00K(+0.8%) | $1.44M(+9.6%) |
| Sep 2004 | - | $357.00K(-20.0%) | $1.32M(+7.2%) |
| Jun 2004 | - | $446.00K(+59.3%) | $1.23M(+0.6%) |
| Mar 2004 | - | $280.00K(+19.7%) | $1.22M(-13.6%) |
| Dec 2003 | $1.41M(+0.9%) | $234.00K(-12.7%) | $1.41M(-17.1%) |
| Sep 2003 | - | $268.00K(-39.0%) | $1.71M(-5.5%) |
| Jun 2003 | - | $439.00K(-7.2%) | $1.80M(+6.2%) |
| Mar 2003 | - | $473.00K(-9.9%) | $1.70M(+21.3%) |
| Dec 2002 | $1.40M(+65.7%) | $525.00K(+42.7%) | $1.40M(+29.0%) |
| Sep 2002 | - | $368.00K(+10.2%) | $1.09M(+16.5%) |
| Jun 2002 | - | $334.00K(+90.9%) | $933.00K(+15.2%) |
| Mar 2002 | - | $175.00K(-16.7%) | $810.00K(-4.3%) |
| Dec 2001 | $846.00K(+15.6%) | $210.00K(-1.9%) | $846.00K(+4.1%) |
| Sep 2001 | - | $214.00K(+1.4%) | $813.00K(+2.4%) |
| Jun 2001 | - | $211.00K(0.0%) | $794.00K(+3.7%) |
| Mar 2001 | - | $211.00K(+19.2%) | $766.00K(+4.6%) |
| Dec 2000 | $732.00K(+83.0%) | $177.00K(-9.2%) | $732.00K(+11.8%) |
| Sep 2000 | - | $195.00K(+6.6%) | $655.00K(+17.0%) |
| Jun 2000 | - | $183.00K(+3.4%) | $560.00K(+17.4%) |
| Mar 2000 | - | $177.00K(+77.0%) | $477.00K(+19.3%) |
| Dec 1999 | $400.00K(+33.3%) | $100.00K(0.0%) | $400.00K(0.0%) |
| Sep 1999 | - | $100.00K(0.0%) | $400.00K(0.0%) |
| Jun 1999 | - | $100.00K(0.0%) | $400.00K(+33.3%) |
| Mar 1999 | - | $100.00K(0.0%) | $300.00K(0.0%) |
| Dec 1998 | $300.00K(0.0%) | $100.00K(0.0%) | $300.00K(0.0%) |
| Sep 1998 | - | $100.00K(>+9900.0%) | $300.00K(0.0%) |
| Jun 1998 | - | $0.00(-100.0%) | $300.00K(-25.0%) |
| Mar 1998 | - | $100.00K(0.0%) | $400.00K(+33.3%) |
| Dec 1997 | $300.00K(+200.0%) | $100.00K(0.0%) | $300.00K(+50.0%) |
| Sep 1997 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jun 1997 | - | $100.00K(-200.0%) | $100.00K(>+9900.0%) |
| Jun 1996 | $100.00K | - | - |
| Mar 1994 | - | -$100.00K(-200.0%) | $0.00(-100.0%) |
| Dec 1993 | - | $100.00K | $100.00K |
FAQ
- What is Moderna annual depreciation & amortization?
- What is the all time high annual D&A for Moderna?
- What is Moderna annual D&A year-on-year change?
- What is Moderna quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Moderna?
- What is Moderna quarterly D&A year-on-year change?
- What is Moderna TTM depreciation & amortization?
- What is the all time high TTM D&A for Moderna?
- What is Moderna TTM D&A year-on-year change?
What is Moderna annual depreciation & amortization?
The current annual D&A of MRNA is $189.00M
What is the all time high annual D&A for Moderna?
Moderna all-time high annual depreciation & amortization is $621.00M
What is Moderna annual D&A year-on-year change?
Over the past year, MRNA annual depreciation & amortization has changed by -$432.00M (-69.57%)
What is Moderna quarterly depreciation & amortization?
The current quarterly D&A of MRNA is $39.00M
What is the all time high quarterly D&A for Moderna?
Moderna all-time high quarterly depreciation & amortization is $249.00M
What is Moderna quarterly D&A year-on-year change?
Over the past year, MRNA quarterly depreciation & amortization has changed by +$3.00M (+8.33%)
What is Moderna TTM depreciation & amortization?
The current TTM D&A of MRNA is $192.00M
What is the all time high TTM D&A for Moderna?
Moderna all-time high TTM depreciation & amortization is $621.00M
What is Moderna TTM D&A year-on-year change?
Over the past year, MRNA TTM depreciation & amortization has changed by -$387.00M (-66.84%)